ARTICLES BY SUZANNE HODSDEN

  • “Bionic” Heart Patch Could Control Arrhythmia
    “Bionic” Heart Patch Could Control Arrhythmia

    Scientists at Harvard are developing a “bionic heart patch” that could be implanted and integrated into a patient’s heart tissue to monitor and regulate arrhythmias with greater precision than a pacemaker. Researchers say the device, which still is in early stages of development, could shed light on the efficacy of pharmaceutical treatments and correct pacing issues using smaller voltages.  

  • GE Healthcare Renews, Expands Partnership With Ultrasound Training Platform Developer
    GE Healthcare Renews, Expands Partnership With Ultrasound Training Platform Developer

    GE Healthcare will renew its partnership with SonoSim, developer of a system that trains clinicians in the use of ultrasound using mannequins and cases simulated from real patients. The collaboration will expand to include GE’s Women’s Health and Urology divisions, and work to accelerate adoption of point-of-care ultrasound technology.

  • Mayo Clinic, GE  To Unveil New Compact MRI Technology
    Mayo Clinic, GE To Unveil New Compact MRI Technology

    Mayo Clinic and GE Global Research plan to introduce a compact 3T magnetic resonance imaging (MRI) scanner at an invitation-only meeting on June 28. The new technology is part of the companies’ five-year bioengineering research partnership, funded by the National Institutes of Health (NIH).

  • Nokia Expands Digital Health Business Through Partnership With Finnish Hospital
    Nokia Expands Digital Health Business Through Partnership With Finnish Hospital

    Nokia has announced a partnership with the Helsinki University Hospital (HUS) in Finland, and the collaboration’s first project will focus on remote monitoring solutions for patients suffering from neurological conditions. This move reflects Nokia’s desire to expand past consumer fitness wearables and into clinical solutions, according to senior leadership.  

  • FDA Releases Final Guidance On Extrapolating Clinical Data For Pediatric Indications
    FDA Releases Final Guidance On Extrapolating Clinical Data For Pediatric Indications

    The FDA has released a final guidance outlining the agency’s thoughts on leveraging data obtained during clinical trials with adults to secure device labeling for pediatric indications. The agency hopes that this new approach will “streamline” the approval process for pediatric devices and improve children’s access to important life-saving technology.

  • Philips Buys Digital Pathology Firm Path XL, Inks Software Partnership
    Philips Buys Digital Pathology Firm Path XL, Inks Software Partnership

    Philips is expanding its foothold in digital pathology with the acquisition of Path XL, a digital imaging analysis (DIA) and software firm based in Ireland, as well as a licensing agreement with Visiopharm, a software company developing algorithms for breast cancer. Philips CEO Frans van Houten commented that he expects Philips digital pathology business to double year over year.

  • U.K.'s NHS Incentivizes Digital Health Technology Use By Hospitals And Caregivers
    U.K.'s NHS Incentivizes Digital Health Technology Use By Hospitals And Caregivers

    The director of the United Kingdom’s National Health Service (NHS) has pledged to put more medtech devices and apps into the hands of patients in order to improve patient outcomes and reduce financial burdens on the nation’s health system. Among his proposals, Simon Stevens introduced a new “tariff” that would incentivize the incorporation of technology into treatment plans, starting in 2017.

  • Swedish Buyout Firm Plans To Sell BSN For $2.2B
    Swedish Buyout Firm Plans To Sell BSN For $2.2B

    EQT, a Swedish private equity group, plans to sell off BSN, which specializes in wound care, vascular care, and orthopedic products, sources told Reuters. EQT is reportedly working with JP Morgan to facilitate the sale, which could be worth over $2.2 billion.

  • FDA Issues Final Rule On Symbols In Medical Device Labeling
    FDA Issues Final Rule On Symbols In Medical Device Labeling

    The FDA has released a final rule governing the use of symbols on device labeling that will allow manufacturers to use standalone symbols — which have been in use overseas for years — without adjacent explanatory text, as long as certain conditions are met. The rule is expected to simplify the labeling process for devices marketed internationally and save manufacturers up to $25.5 million.

  • White House Invests $160M In Artificial Tissue Biofabrication Technology
    White House Invests $160M In Artificial Tissue Biofabrication Technology

    The White House has launched an initiative to reduce the amount of time patients have wait for organ donations, by encouraging and facilitating living donation and by investing in new technology that could provide artificial alternatives to living tissue. Together with a group of universities and private sector companies, the Department of Defense (DOD) plans to invest $160 million in the Advanced Tissue Biofabrication Manufacturing Innovation Institute (ATB-MII).

More Articles by Suzanne Hodsden

Suzanne Hodsden

Suzanne Hodsden is a contributor who writes regular life sciences news features for several publications. She holds degrees from Denison University and Bowling Green State University.